年龄校正HbA1c更准确量化成人1型糖尿病进展风险
本研究基于TrialNet Pathway to Prevention研究中5,024例自身抗体阳性亲属(3,720例儿童和1,304例成人),评估年龄校正HbA1c或更高HbA1c阈值(≥6.0% [42 mmol/mol])能否改善不同年龄组的风险分层。结果显示,年龄校正可减少儿童与成人进展风险差异,而HbA1c≥6.0%阈值使成人与儿童风险相当,提示年龄特异性风险分层可能更准确。
要点
- 标准HbA1c阈值≥5.7%可能高估成人1型糖尿病进展风险。
- 年龄校正HbA1c可减少儿童与成人进展风险差异。
- 成人采用HbA1c≥6.0%阈值与儿童进展风险相当。
核心结论
- 年龄相关HbA1c变化影响成人1型糖尿病风险分层,年龄校正HbA1c或成人采用≥6.0%阈值可识别与儿童进展风险相当者。
研究设计与样本
- 分析TrialNet Pathway to Prevention研究中5,024例自身抗体阳性亲属(3,720例儿童和1,304例成人),并使用Exeter 10000队列中6,273例成人建模年龄相关HbA1c效应。
主要发现
- 使用HbA1c≥5.7%阈值时,单抗体阳性儿童1年进展风险38%(95%CI 28,47)高于成人13%(95%CI 7.2,19),多抗体阳性儿童55%(95%CI 49,60)高于成人38%(95%CI 27,47)(均P<0.001)。
- 年龄校正后,单抗体阳性者儿童与成人进展风险相似(38% [95%CI 28,47] vs. 27% [95%CI 13,39];P=0.32),多抗体阳性者差异减弱。
- HbA1c≥6.0%阈值使各抗体亚组成人与儿童进展风险相当;事后分析中<30岁成人进展风险与儿童相似(P=0.1)。
关键数值与推荐
- 标准异常血糖阈值:HbA1c≥5.7%(39 mmol/mol);替代阈值:HbA1c≥6.0%(42 mmol/mol)。
临床怎么用
- 在1型糖尿病预防设置中,可考虑对成人采用年龄校正HbA1c或更高阈值(≥6.0% [42 mmol/mol])进行风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: HbA1c thresholds used to define dysglycemia in autoantibody-positive individuals at risk for type 1 diabetes do not account for age-related increases in HbA1c and may overestimate progression risk in adults. We evaluated whether age-adjusted HbA1c or a higher HbA1c threshold improves risk stratification across age-groups. RESEARCH DESIGN AND METHODS: We analyzed 5,024 autoantibody-positive relatives (3,720 children and 1,304 adults) participating in the TrialNet Pathway to Prevention study. Age-related HbA1c effects were modeled using 6,273 adults from the population-based Exeter 10000 cohort. Progression risk was compared using the standard dysglycemia threshold (HbA1c ≥5.7% [39 mmol/mol]), age-adjusted HbA1c, and an alternative threshold of HbA1c ≥6.0% (42 mmol/mol). RESULTS: Using HbA1c ≥5.7% (39 mmol/mol), children had higher 1-year progression risk than adults among single autoantibody-positive participants (38% [95% CI 28, 47] vs. 13% [7.2, 19]) and multiple autoantibody-positive participants (55% [49, 60] vs. 38% [27, 47]) (both P < 0.001). Age adjustment reduced these differences; progression risk was similar among single autoantibody-positive participants (38% [28, 47] vs. 27% [13, 39]; P = 0.32), with attenuated differences among multiple autoantibody-positive participants. An HbA1c threshold ≥6.0% (42 mmol/mol) yielded comparable progression risk between adults and children across autoantibody subgroups. In post hoc analyses, adults aged <30 years had progression risk similar to children (P = 0.1). CONCLUSIONS: Age-related variation in HbA1c influences dysglycemia classification in adults at risk for type 1 diabetes. Age-adjusted HbA1c or a higher HbA1c threshold (≥6.0% [42 mmol/mol]) in adults aged ≥30 years identifies individuals with progression risk comparable to children and may improve age-specific risk stratification in prevention settings.
引用
- Templeman EL, Thomas N, Martin S, et al. Accounting for Age-Related Increases in HbA1c More Accurately Quantifies Risk of Type 1 Diabetes Progression in Islet Autoantibody-Positive Adults. Diabetes Care. 2026. PMID: 42090204. doi:10.2337/dc26-0446
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。